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ABSTRACT
INTRODUCTION The incidence of gastro-oesophageal reflux disease and obesity has increased significantly in recent years. The
number of antireflux procedures being carried out on people with a higher body mass index (BMI) has been rising. Evidence is con-
flicting for outcomes of antireflux surgery in obese patients in terms of its safety and efficacy. Given the contradictory reports, this
meta-analysis was undertaken to establish the outcomes of antireflux surgery (ARS) in obese patients and its associated safety.
METHODS A systematic electronic search was conducted using the PubMed, MEDLINE®, Ovid®, Cochrane Library and Google
Scholar™ databases to identify studies that analysed the effect of BMI on the outcomes of ARS. A meta-analysis was performed
using the random effects model. The intraoperative and postoperative outcomes that were examined included operative time, con-
version to an open procedure, mean length of hospital stay, recurrence of acid reflux requiring reoperation and wrap migration.
RESULTS A total of 3,772 patients were included in 13 studies. There was no significant difference in procedure conversion rate,
recurrence of reflux requiring reoperation or wrap migration between obese and non-obese patients. However, both the mean opera-
tive time and mean length of stay were longer for obese patients.
CONCLUSIONS ARS in obese patients with gastro-oesophageal reflux disease is safe and outcomes are comparable with those in
patients with a BMI in the normal range. A high BMI should therefore not be a deterrent to considering ARS for appropriate
patients.
KEYWORDS
High body mass index – Antireflux surgery – Fundoplication – Obesity
Accepted 9 April 2017
CORRESPONDENCE TO
Ashutosh Tandon, E: drashutoshtandon@gmail.com
Gastro-oesophageal reflux disease (GORD) is increasingly
encountered, having an estimated prevalence of up to 20%
in the Western hemisphere.1 Antireflux surgery (ARS) for
GORD is cost effective compared with medical management
in the long term,2 with laparoscopic ARS being the gold
standard.3,4
Obesity has doubled globally in the last three decades,
and epidemiological studies suggest an association between
obesity and GORD5 as a result of distorted pressure gra-
dients across the gastro-oesophageal junction.6 Conse-
quently, ARS is increasingly being carried out on people with
a higher body mass index (BMI). Evidence for outcomes of
ARS on obese patients is conflicting in terms of its safety and
efficacy.7–11 This systematic review and meta-analysis was
undertaken with a view to informing future practice.
Methods
A systematic electronic search was undertaken using
PubMed, MEDLINE®, Ovid®, Cochrane Library and Google
Scholar™ according to PRISMA (Preferred Reporting Items
for Systematic Reviews and Meta-Analyses) guidance.12
Search terms comprised “obesity” OR “high BMI”AND “anti-
reflux surgery” OR “Nissen fundoplication” OR “fundoplica-
tion”. All search terms were combined with Boolean
operators and searched as both keywords and Medical Sub-
ject Headings. The results were reviewed by two independ-
ent researchers (AT and QMN). The last search date was
10 October 2016.
Inclusion and exclusion criteria
Studies were included in this review if they looked at the
effect of BMI on the outcome of laparoscopic fundoplication.
Case reports, letters, editorials, conference abstracts, non-
English articles and animal studies were excluded, as were
studies investigating bariatric surgery as ARS.
Outcome measures
The World Health Organization classification of BMI was
used: normal BMI 18.5–24.9kg/m2, overweight ≥25kg/m2
and obese ≥30kg/m2.13 Outcomes included operative time,
conversion to open procedure, mean length of hospital stay,
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recurrence of acid reflux requiring reoperation and wrap
migration. Data were also collected for preoperative assess-
ment, including lower oesophageal pressure, total acid
exposure time on 24-hour pH monitoring, DeMeester score,
presence of Barrett’s oesophagus, presence of reflux oeso-
phagitis, type of fundoplication and follow-up duration.
Study selection
Two authors (AT and QMN) independently performed the
search. Disagreements on study selection were resolved by
consensus with the senior author (RG). If the issue of study
selection was still not resolved, the lead author’s (NH’s) deci-
sion was considered final.
Statistical analysis
Statistical analysis was undertaken using RevMan version
5.3 (Nordic Cochrane Centre, Copenhagen, Denmark). Data
were pooled and rate differences as well as standard mean
differences (SMDs) with 95% confidence intervals (CIs)
were calculated. The random effects model was used as the
effects were expected to be heterogeneous owing to the vari-
ety of study populations and study designs included in the
analysis.14 Heterogeneity was tested using the I2 statistic.
Quality assessment
The methodological index for non-randomised studies
(MINORS)15 was used to evaluate methodological quality
and potential bias of included studies.
Results
Overall, 8,470 articles were identified. Following exclusion
of duplicates, non-English articles and animal studies, 2,124
articles remained. The titles and abstracts were then
reviewed, and a further 2,103 articles were excluded. Of the
remaining 21 articles, 8 were excluded owing to being
smaller case series and studies reporting inappropriate out-
comes. Finally, 13 studies were left for review (Fig 1).7–11,16–
23 No randomised controlled trials (RCTs) were identified.
Eight of the studies were prospective7,9,10,16,18,19,21,23 and
five were retrospective.8,11,17,20,22
Study and patient characteristics
A total of 3,772 patients were included in the 13 studies.
Seven studies reported on patients in all three categories of
BMI,7,8,10,16,18,19,23 three studies reported on patients with
BMI <30kg/m2 and BMI ≥30kg/m2,9,17,20 and one study
reported on patients with normal BMI and patients who
were obese.11 The mean or median age was reported in six
studies.7,10,16,20,21,23 There were 1,942 male and 1,464 female
patients in 12 studies (Table 1).7–11,16–19,21–23 Co-morbidities
were not reported in any of the studies.
Conversion from laparoscopic to open procedure
Six studies reported conversion of laparoscopic procedures
to open procedures.7,11,18,20,21,23 Two of these stated there







Title and abstract screening n=2,075
Case reports n=28
Relevant studies retrieved for more
detailed evaluation
n=2,124
Potentially relevant studies identified
through databases and screnned for
retrieval
n=8,470
Potentially appropriate studies to be
included in the analysis
n=21




Case series (<10 cases) n=5
Figure 1 Flowchart of studies included in review
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conversion for BMI <30kg/m2 and BMI ≥30kg/m2 as 1.2%
(23/1,931) and1.4% (10/694) respectively with a combined
risk ratio (RR) of 0.97 (95% CI: 0.46–2.07, p=0.94). Heteroge-
neity was 0% (Fig 2).
Recurrence of reflux requiring reoperation
Recurrence was compared in five studies.8,9,18,20,23 There
was no significant difference in recurrence rate between the
BMI <30kg/m2 and BMI ≥30kg/m2 groups (3.1% [53/1,698]
vs7.5% [40/536] respectively) with a combined RR of 1.99
(95% CI: 0.85–4.65, p=0.11). Heterogeneity was 62% (Fig 3).
Wrap migration
Four studies compared wrap migration at follow-up
review.9,11,18,20 There was no significant difference in the
number of patients who had wrap migration between the
BMI <30kg/m2 and BMI ≥30kg/m2 groups (1.0% [7/694]
vs1.3% [5/396] respectively) with a combined RR of 1.23
(95% CI: 0.37–4.03, p=0.73). Heterogeneity was 0% (Fig 4).
Operative time
Seven studies reported the mean operative time with range
or standard deviation.7–9,18,20,21,23 There was a significant





BMI ≤24kg/m2 BMI 25–30kg/m2 BMI ≥30kg/m2 Mean / median
age in yrs
Sex ratio
Fraser, 20017 Prospective 13/24 194 40 (21%) 88 (45%) 66 (34%) Mean 46.9
(range: 17–74)
M=60%, F=40%
Perez, 20018 Retrospective 14/24 224 89 (40%) 87 (39%) 48 (21%) M=53%, F=47%
Anvari, 20069 Prospective 23/24 140 70 (50%) 70 (50%) M=50%, F=50%
Morgenthal, 200710 Prospective 6/16 174 21 (12%) 47 (27%) 22 (13%) Mean 47.1 ±13.9
(range: 12–77)
M=55%, F=45%
Luketina, 201511 Retrospective 21/24 80 40 (50%) 0 (0%) 40 (50%) M=56%, F=44%









Hahnloser, 200217 Retrospective 10/16 126 75 (60%) 51 (41%) M=56%, F=44%
Winslow, 200318 Prospective 18/24 505 82 (16%) 210 (42%) 212 (42%) M=52%, F=48%
D’Alessio, 200519 Prospective 17/24 257 79 (31%) 116 (45%) 62 (24%) M=45%, F=55%
Ng, 200720 Retrospective 13/24 366 292 (80%) 74 (20%) Mean 44
(range: 12–86)
Chisholm, 200921 Prospective 14/24 481 103 (21%) 208 (43%) 170 (36%) Mean 50.3
(range: 16–91)
M=58%, F=42%
Irino, 201022 Retrospective 12/16 26 M=65%, F=35%
Tekin, 201223 Prospective 19/24 1,000 484 (48%) 384 (38%) 132 (13%) Mean 39.64
±10.58
M=61%, F=39%
BMI = body mass index; MINORS = methodological index for non-randomised studies
Figure 2 Forest plot comparing rates of conversion from laparoscopic to open fundoplication for body mass index (BMI) <30kg/m2 and
BMI ≥30kg/m2. A random effects model was used for meta-analysis. Risk ratios are shown with 95% confidence intervals.
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difference, ranging from 55.9 minutes to 152 minutes in
obese patients and 48.05 minutes to 144 minutes in patients
with BMI <30kg/m2 (SMD: 1.24 minutes, 95% CI: 0.46–2.02
minutes, p=0.002). Heterogeneity was 98% (Fig 5).
Length of stay
The mean length of hospital stay in both groups was
reported in five studies.9,18–20,23 This was significantly lower
in the normal weight group, ranging from 1.09 to 2.2 days
compared with a range of 1.08–3.17 days in the obese group
(SMD: 1.11 days, 95% CI: -0.16–2.06 days, p=0.020). Hetero-
geneity was 98% (Fig 6).
Follow-up duration
The mean or median follow-up duration was reported in 11
studies (Table 2).7–9,11,16–19,21–23 The minimum mean follow-
up duration was 14.7 months,11 the maximum being 96
months.21
Type of antireflux surgery
The type of ARS performed was reported in all studies
(Table 2). In seven of the studies, laparoscopic Nissen fundo-
plication (LNF) was performed in all patients.7,9,10,16,17,19,20
Perez et al carried out LNF and Belsey Mark IV procedures,
noting that the transthoracic approach in the latter operation
was technically easier for obese patients.8 Although Chis-
holm et al chose LNF and laparoscopic anterior fundoplica-
tion for the majority of their patients, 2% underwent
laparoscopic Toupet fundoplication (LTF).21 Their choice of
procedure was not influenced by BMI. In the remaining four
studies, just LNF and LTF were performed, with Winslow et
al18 and Tekin et al23 favouring LNF while Luketina et al11
and Irino et al22 favoured LTF.
Quality of studies
The quality of the studies was evaluated with the MINORS
criteria (Table 1).15 The highest score achieved by a non-
comparative study was 12/16.22 For comparative studies, the
highest score was 23/24.9 Three studies concluded that ARS
had a poor outcome in high BMI patients (Table 3).8,10,17
Discussion
Laparoscopic fundoplication is the established gold standard
for surgical treatment of GORD.4,24 ARS in obese patients is
technically challenging owing to body habitus, the abun-
dance of intraperitoneal fat and hepatic hypertrophy. As high
BMI is the main precipitating factor for GORD, if it remains
untreated, it could theoretically bring about failure of the
ARS. Patients with a high BMI are prone to an increased rate
of postoperative complications and a lower success rate.10,17
Bariatric operations are becoming more common and are
associated with low complication rates. Roux-en-Y gastric
bypass is the most frequently undertaken bariatric proce-
dure, and it has been shown to be effective in achieving
weight loss and also in treating reflux in these patients.25
Conversely, however, many studies have reported that con-
struction of a sound wrap in obese patients has outcomes
Figure 3 Forest plot comparing recurrence of reflux requiring reoperation for body mass index (BMI) <30kg/m2 and BMI ≥30kg/m2. A
random effects model was used for meta-analysis. Risk ratios are shown with 95% confidence intervals.
Figure 4 Forest plot comparing rates of migration of wrap for body mass index (BMI) <30kg/m2 and BMI ≥30kg/m2. A random effects
model was used for meta-analysis. Risk ratios are shown with 95% confidence intervals.
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that are comparable with those for people with normal BMI
in terms of both complications and failure.9,11,18
This review was undertaken to compare outcomes of ARS
(operative time, length of stay and conversion rates) as well
as complications for normal and high BMI patients. Our
meta-analysis included eight prospective trials and five ret-
rospective studies. Eight of these classified BMI into three
categories7,8,10,11,16–19,21–23 while two studies grouped results
by BMI <30kg/m2 and BMI ≥30kg/m2.9,20 None of the studies
detailed any coexisting co-morbidities for their cohort. Obe-
sity associated cardiovascular, respiratory and endocrine co-
morbidities carry unique challenges when patients are con-
sidered for surgery, and they can influence outcomes.
In this meta-analysis, the mean operative time reported in
seven studies was significantly longer for obese patients.
Interestingly, conversion rates in six studies were similar for
the BMI <30kg/m2 and BMI ≥30kg/m2 groups (1.2% vs 1.4%
respectively, p=0.94), which may be indicative of the compe-
tent laparoscopic skills of the surgeons in these studies and
their familiarity with operating on people with raised BMI.
Only four studies reported on the occurrence of wrap migra-
tion (1.0% for BMI <30kg/m2 vs 1.3% for BMI ≥30kg/m2) and
the difference between the groups was not statistically sig-
nificant. Follow-up duration was reported in 8 studies with a
minimum mean of over 14 months.
In seven studies, LNF was carried out on all patients,
making it the most common procedure. Perez et al com-
pared the LNF and Belsey Mark IV procedures in 224
patients, reporting that the transthoracic procedure was
technically easier in obese patients as it gave good exposure
of the hiatus.8 However, this was associated with a higher
recurrence in the obese group. Chisholm et al reported out-
comes in 481 patients, the majority of whom underwent LNF
(67%) followed by laparoscopic anterior fundoplication
(31%) and LTF (2%).21 The choice of wrap was not influ-
enced by BMI and outcomes were not affected by BMI or sex
of the patient. Irino et al undertook 14 LTF and 12 LNF pro-
cedures, and found patients with BMI >25kg/m2 had better
outcomes than those with BMI <25kg/m2.22 Obesity was not
associated with inferior outcomes when Luketina et al com-
pared the outcomes of LTF (n=58) with LNF (n=22) although
it should be noted that the follow-up period was only 12
months.11 Winslow et al predominantly undertook LNF in
their 505 patients, with longer operative times in obese
patients.18
This meta-analysis comprised non-randomised studies as
there is a dearth of RCTs on the subject. The inclusion of
non-randomised studies in meta-analyses is a matter of
ongoing debate.26 While RCTs are considered the gold
standard for evidence-based practice, non-randomised stud-
ies are increasingly being included in meta-analyses as both
types of studies are associated with their unique strengths
and weaknesses.27 Designed to minimise bias, RCTs can be
restrictive in their selection criteria. On the other hand, non-
randomised studies tend to be more representative of patient
populations seen in routine clinical practice.28 The approach
of analysing non-randomised studies in a systematic manner
through a meta-analysis is becoming more prevalent as the
resulting information can play an important role in inform-
ing practice and investigation.27,29,30
Figure 5 Forest plot comparing operative time for body mass index (BMI) <30kg/m2 and BMI ≥30kg/m2. A random effects model was
used for meta-analysis. Risk ratios are shown with 95% confidence intervals.
Figure 6 Forest plot comparing length of hospital stay for body mass index (BMI) <30kg/m2 and BMI ≥30kg/m2. A random effects model
was used for meta-analysis. Risk ratios are shown with 95% confidence intervals.
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Study limitations
There are several limitations to this review. The included
studies were from single centres and were mostly retrospec-
tive. None of the studies fulfilled all of the MINORS criteria,15
meaning that firm conclusions cannot be drawn. The inci-
dence of postoperative symptoms (dysphagia, food intoler-
ance, belching), continued use of medications (proton pump
inhibitors, H2 blockers) and satisfaction scores were not
reported adequately in the included studies. Furthermore,
caution is advised in the interpretation of the results with
respect to very severely obese patients (BMI >40kg/m2)
undergoing ARS in clinical practice as all patients with BMI
>30kg/m2 were grouped together in a single obese category
in the studies included in our analysis. However, given the
lack of currently available literature, our review adds impor-
tant information on antireflux surgery in obese patients.
Conclusions
Analysis of pooled data revealed that ARS in obese patients
with GORD is safe and outcomes are comparable with those
for patients with a BMI in the normal range. LNF is the most
commonly undertaken procedure in obese patients, with
acceptable conversion rates. The mean operative time and
mean length of hospital stay were prolonged in the high BMI
group but complication and reoperation rates were not sig-
nificantly higher. Consequently, a high BMI should not be a
deterrent to considering ARS for appropriate patients.
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